🇺🇸 FDA
Patent

US 7067256

Ribozyme mediated inactivation of the androgen receptor

granted A61KA61K38/00

Quick answer

US patent 7067256 (Ribozyme mediated inactivation of the androgen receptor) held by The Board of Regents of the University of Texas System expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K38/00